The Master of Science in Biological Sciences is a research intensive program designed to address one of the most important topics of our times. The program's goal is to train students for scientific careers focused on biomedicine, including understanding the aging process, as well as detecting, preventing, and treating age- and metabolic-related conditions such as Alzheimer's, Parkinson's disease, cancer, stroke, and arthritis.
Students in this program will be trained as scientists in interdisciplinary research encompassing genetics, biochemistry, molecular biology, cell and developmental biology, neurobiology, environmental sciences and disciplines of biotechnology including genomics, proteomics, proteins interaction networks and bio-informatics.
In Fall 2008 Dominican collaborated with the Buck Institute to offer a master's degree in biological sciences with an emphasis on age research. The Buck Institute is the first independent research facility in the United States to focus solely on aging and age-related conditions. The National Institute on Aging designated the Buck Institute as a "Nathan Shock Center of Excellence in the Biology of Age Research" in June 2005, one of just five in the nation.
In Fall 2009 Dominican added BioMarin to its master's degree in biological sciences with an emphasis on developing and commercializing innovative biopharmaceuticals. With four products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
The Master of Science in Clinical Laboratory Sciences with an emphasis in Molecular Diagnostics is a 36-unit, non-thesis program, for future leaders in the clinical laboratory. The program’s primary goal is to provide advanced training to students who are already CLS-licensed or CLS-license eligible. Students in the CLS program will be prepared to modify systems and procedures in an effort to make the clinical lab more efficient and cost-effective while still emphasizing the importance of obtaining accurate and reproducible patient results. Molecular diagnostic techniques covered by this program include nucleic acid and protein extraction, gel electrophoresis, PCR, fluorescent in situ hybridization (FISH), restriction fragment length polymorphism (RFLP) analysis, and DNA and RNA microarray technology.